Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

12.98
Delayed Data
As of Sep 01
 -0.48 / -3.57%
Today’s Change
5.34
Today|||52-Week Range
19.43
+112.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues13.2M48.3M11.4M12.6M
 
 
 
 
 
Depreciation And Amortization1.4M1.4M1.4M1.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses33.7M33.1M31.3M36.4M
 
 
 
 
 
Research And Development28.0M27.6M25.7M30.4M
 
 
 
 
 
Total Operating Expenses35.1M34.5M32.7M37.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.9M13.8M-21.2M-25.1M
 
 
 
 
 
Interest Expense On Debt0.000.000.005.4M
 
 
Other Expenses-380.0K-160.0K-393.0K16.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.3M13.6M-21.6M-30.5M
 
 
 
 
 
Net Income-22.3M13.6M-21.6M-30.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS85.9M85.9M86.1M86.3M
 
 
 
 
 
Shares To Calculate EPS Diluted85.9M86.7M86.1M86.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26$0.16-$0.25-$0.35
 
 
 
 
 
EPS Diluted-$0.26$0.16-$0.25-$0.35